Physician profile
Steven Frederick Stanowicz
NPI 1649204520
$2,325.50
in general payments reported to CMS, 2019-2025
22 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $202 · 2021: $556 · 2022: $377 · 2023: $165 · 2024: $96.24 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $646.94 | 2019-2025 | |
| Abbvie INC. | $445.65 | 2019-2024 | Rinvoq |
| Regeneron Healthcare Solutions, INC. | $226.85 | 2019-2021 | |
| Leo Pharma INC. | $201.46 | 2019-2022 | |
| Lilly USA, LLC | $141.80 | 2019-2022 | |
| Merz North America, INC. | $75.00 | 2021 | |
| Genzyme Corporation | $74.30 | 2021-2022 | |
| Janssen Biotech, INC. | $73.97 | 2019-2021 | |
| Galderma Laboratories, L.P. | $67.89 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $59.13 | 2023 | Sotyktu |
| Incyte Corporation | $48.62 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $42.58 | 2019 | |
| Pfizer INC. | $42.36 | 2020-2021 | |
| Almirall LLC | $37.41 | 2019-2022 | |
| Prugen, INC. Pharmaceuticals | $25.30 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $23.63 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.41 | 2019 | |
| Mayne Pharma Commercial LLC | $18.13 | 2020 | |
| Aclaris Therapeutics, INC. | $17.22 | 2019 | |
| Dermavant Sciences, INC. | $13.65 | 2022 | |
| Allergan, INC. | $13.48 | 2019 | |
| Vyne Pharmaceuticals INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stanowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.